Skip to main content

Our Scientific Background

We have revealed that uterine defects predates pregnancy-related diseases bringing new opportunities for early detection and prevention strategies

DNA icon
Clinical study


Preeclampsia accounts for thousands of maternal and infant deaths worldwide
It’s characterized by hypertension, proteinuria and organ damage and long-term consequences such as cardiovascular diseases
A full understanding of the pathogenesis of PE remains elusive and new treatments are needed.

Early prediction is essential for reducing health impact in mothers and their babies

Our research provides evidence of a maternal contribution to preeclampsia based on defective decidualization during and years after pregnancy

Pregnant woman

Our technology improves pregnancy health by taking a novel utero-centric concept of preeclampsia


Decidualization prepares the uterus for embryo invasion and placentation​
Uterus icon
We demonstrated a maternal contribution to severe preeclampsia through defective decidualization


The placenta provides nutrients and oxygen to the embryo
Decidua icon
Defective decidualization impacts maternal and fetal communication during abnormal placentation​


C-RNA molecules reflect dynamic changes in pregnancy health
RNA molecules icon
Our technology based on C-RNA sequencing enables to predict pregnancy complications before symptoms appear​

Our investigation decidualization opens up new horizons for identifying circulating RNAs that can predict complications early during pregnancy


Our Main Publications

Main publications infographic

Our Main Publications

Main publications infographic

Access them here